Search research articles
Contact Us
Filters
Showing results (81-90 of 106) with videos related to
Page
of 11
Sort By:
Journal of Endocrinological Investigation
|
November 11, 2008
The continuous infusion of acylated ghrelin enhances growth hormone secretion and worsens glucose metabolism in humans
F Broglio, F Prodam, F Riganti, et al.
Neuropeptides
|
November 23, 2006
d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans
A Benso, F Prodam, B Lucatello, et al.
Journal of Endocrinological Investigation
|
November 5, 2003
Effects of cortistatin-14 and somatostatin-14 on the endocrine response to hexarelin in humans
A Benso, C Gottero, F Prodam, et al.
Acta Diabetologica
|
August 8, 2008
Sleep abnormalities in type 2 diabetes may be associated with glycemic control
M Trento, F Broglio, F Riganti, et al.
Journal of Endocrinological Investigation
|
February 18, 2024
Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study
B M Bonora, G Russo, F Leonetti, et al.
Endocrine
|
April 27, 2001
Biologic activities of growth hormone secretagogues in humans
E Ghigo, E Arvat, R Giordano, et al.
European Journal of Endocrinology
|
March 31, 1999
Radionuclide angiocardiographic evaluation of the cardiovascular effects of recombinant human IGF-I in normal adults
G Bisi, V Podio, M R Valetto, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
|
September 1, 2004
Cortistatin-17 and -14 exert the same endocrine activities as somatostatin in humans
C Gottero, F Prodam, S Destefanis, et al.
European Journal of Endocrinology
|
January 9, 2013
The GH-releasing effect of acylated ghrelin in normal subjects is refractory to GH acute auto-feedback but is inhibited after short-term GH administration inducing IGF1 increase
A Benso, E Gramaglia, I Olivetti, et al.
Endocrine
|
April 27, 2001
Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death
N Filigheddu, A Fubini, G Baldanzi, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 106) with videos related to
Sort By:
Page
of 11
Journal of Endocrinological Investigation
|
November 11, 2008
The continuous infusion of acylated ghrelin enhances growth hormone secretion and worsens glucose metabolism in humans
F Broglio, F Prodam, F Riganti, et al.
Neuropeptides
|
November 23, 2006
d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans
A Benso, F Prodam, B Lucatello, et al.
Journal of Endocrinological Investigation
|
November 5, 2003
Effects of cortistatin-14 and somatostatin-14 on the endocrine response to hexarelin in humans
A Benso, C Gottero, F Prodam, et al.
Acta Diabetologica
|
August 8, 2008
Sleep abnormalities in type 2 diabetes may be associated with glycemic control
M Trento, F Broglio, F Riganti, et al.
Journal of Endocrinological Investigation
|
February 18, 2024
Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study
B M Bonora, G Russo, F Leonetti, et al.
Endocrine
|
April 27, 2001
Biologic activities of growth hormone secretagogues in humans
E Ghigo, E Arvat, R Giordano, et al.
European Journal of Endocrinology
|
March 31, 1999
Radionuclide angiocardiographic evaluation of the cardiovascular effects of recombinant human IGF-I in normal adults
G Bisi, V Podio, M R Valetto, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
|
September 1, 2004
Cortistatin-17 and -14 exert the same endocrine activities as somatostatin in humans
C Gottero, F Prodam, S Destefanis, et al.
European Journal of Endocrinology
|
January 9, 2013
The GH-releasing effect of acylated ghrelin in normal subjects is refractory to GH acute auto-feedback but is inhibited after short-term GH administration inducing IGF1 increase
A Benso, E Gramaglia, I Olivetti, et al.
Endocrine
|
April 27, 2001
Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death
N Filigheddu, A Fubini, G Baldanzi, et al.
Page
of 11